Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Equity (2016 - 2025)

Historic Return on Equity for Akebia Therapeutics (AKBA) over the last 10 years, with Q3 2025 value amounting to 0.45%.

  • Akebia Therapeutics' Return on Equity fell 15400.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 15400.0%. This contributed to the annual value of 1.74% for FY2024, which is 23600.0% down from last year.
  • Akebia Therapeutics' Return on Equity amounted to 0.45% in Q3 2025, which was down 15400.0% from 1.36% recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Return on Equity registered a high of 8.45% during Q1 2023, and its lowest value of 5.78% during Q1 2022.
  • In the last 5 years, Akebia Therapeutics' Return on Equity had a median value of 0.21% in 2022 and averaged 0.3%.
  • In the last 5 years, Akebia Therapeutics' Return on Equity surged by 142300bps in 2023 and then plummeted by -69600bps in 2024.
  • Over the past 5 years, Akebia Therapeutics' Return on Equity (Quarter) stood at 2.69% in 2021, then soared by 105bps to 0.12% in 2022, then surged by 1088bps to 1.48% in 2023, then fell by -6bps to 1.39% in 2024, then tumbled by -132bps to 0.45% in 2025.
  • Its last three reported values are 0.45% in Q3 2025, 1.36% for Q2 2025, and 3.68% during Q1 2025.